1 | 11C-csar | - | - | - | - | 2件: 93 93, 94 💬
|
2 | 45 GY external radiations | - | - | - | - | 1件: 94 94 💬
|
3 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 10件: 34 34, 51, 53, 85, 94, 97, 193, 233, 298, 299 💬
|
4 | Acido deossicolico | - | - | - | - | 1件: 94 94 💬
|
5 | Acido obeticolico | - | - | - | - | 3件: 93 93, 94, 296 💬
|
6 | Alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬
| - | - | 3件: 70 70, 94, 298 💬
|
7 | Aldafermin | 1件: Aldafermin Aldafermin | 1件: Aldafermin
Aldafermin
💬
| 1件: FGF19 FGF19 💬
| 10件: Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | 1件: 94 94 💬
|
8 | ALL-trans retinoic acid | 1件: Tretinoin Tretinoin | 1件: Tretinoin
Tretinoin
💬
| 3件: PML PML, RARA, RARB 💬
| 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 94 94 💬
|
9 | Aramchol meglumine | 1件: Aramchol Aramchol | - | - | - | 1件: 94 94 💬
|
10 | Atra | 1件: Tretinoin Tretinoin | 1件: Tretinoin
Tretinoin
💬
| 3件: PML PML, RARA, RARB 💬
| 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 2件: 63 63, 94 💬
|
11 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
12 | AZT | - | - | - | - | 3件: 94 94, 265, 325 💬
|
13 | Befizal L.P. 400 MG, comprimé enrobé à LIBération prolongéE | - | - | - | - | 1件: 94 94 💬
|
14 | Bexotegrast | 1件: Bexotegrast Bexotegrast | 1件: Bexotegrast
Bexotegrast
💬
| 3件: ITGA5 ITGA5, ITGB1, ITGB6 💬
| 31件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Axon guidance, Bacterial invasion of epithelial cells, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Leishmaniasis, Leukocyte transendothelial migration, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pertussis, Phagosome, Platelet activation, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Shigellosis, Small cell lung cancer, Tight junction, Toxoplasmosis, Virion - Herpesvirus, Virion - Rotavirus, Yersinia infection 💬 | 1件: 94 94 💬
|
15 | Bezafibrate | 1件: Bezafibrate Bezafibrate | 1件: Bezafibrate
Bezafibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 8件: 20 20, 93, 94, 160, 296, 316, 324, 344 💬
|
16 | Bezafibrate (400MG) IN addition TO standard 15-20 MG/KG/jour udca therapy | 2件: Bezafibrate Bezafibrate, Ursodeoxycholic acid | 2件: Ursodiol
Ursodiol
,
Bezafibrate
💬
| 2件: NR1C1 NR1C1, NR1H4 💬
| 11件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 94 94 💬
|
17 | Bezalip | - | - | - | - | 2件: 93 93, 94 💬
|
18 | Blood draw FOR THE laboratory assessment | - | - | - | - | 2件: 94 94, 303 💬
|
19 | Bromlein | - | - | - | - | 2件: 94 94, 97 💬
|
20 | BRS201 | - | - | - | - | 2件: 94 94, 97 💬
|
21 | BTT1023 | - | - | - | - | 1件: 94 94 💬
|
22 | BTT1023 IV infusion 20 MG/ML, 5 ML drug product | - | - | - | - | 1件: 94 94 💬
|
23 | Budesonide | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 66 66, 93, 94, 95, 96, 97, 98 💬
|
24 | C10ab02 | - | - | - | - | 1件: 94 94 💬
|
25 | Capecitabine | 1件: Capecitabine Capecitabine | 1件: Capecitabine
Capecitabine
💬
| 1件: thyA thyA 💬
| 3件: Folate transport and metabolism Folate transport and metabolism, One carbon pool by folate, Pyrimidine metabolism 💬 | 1件: 94 94 💬
|
26 | Cenicriviroc 150 MG | 1件: Cenicriviroc Cenicriviroc | 2件: Cenicriviroc
Cenicriviroc
,
Cenicriviroc mesylate
💬
| 2件: CCR2 CCR2, CCR5 💬
| 11件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | 1件: 94 94 💬
|
27 | Cilo | - | - | - | - | 1件: 94 94 💬
|
28 | Cilofexor | 1件: Cilofexor Cilofexor | - | - | - | 2件: 93 93, 94 💬
|
29 | CIS-4-hydroxy-L-proline | - | - | - | - | 1件: 94 94 💬
|
30 | Cladribine | 1件: Cladribine Cladribine | 1件: Cladribine
Cladribine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 3件: 11 11, 13, 94 💬
|
31 | CM-101 | 1件: CM-101 CM-101 | - | - | - | 2件: 51 51, 94 💬
|
32 | Contrast media, magnetic resonance | - | - | - | - | 2件: 94 94, 96 💬
|
33 | CS0159 | - | - | - | - | 2件: 93 93, 94 💬
|
34 | Curcumin | 1件: Curcumin Curcumin | - | - | - | 10件: 13 13, 34, 46, 67, 74, 94, 96, 97, 139, 299 💬
|
35 | DHA | - | - | - | - | 4件: 6 6, 46, 94, 299 💬
|
36 | Docosahexaenoic acid | 1件: Doconexent Doconexent | - | - | - | 6件: 6 6, 49, 90, 94, 240, 299 💬
|
37 | DUR-928 | - | - | - | - | 1件: 94 94 💬
|
38 | Elafibranor | 1件: Elafibranor Elafibranor | 1件: Elafibranor
Elafibranor
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 2件: 93 93, 94 💬
|
39 | Elafibranor 120 MG | 1件: Elafibranor Elafibranor | 1件: Elafibranor
Elafibranor
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 2件: 93 93, 94 💬
|
40 | Elafibranor 80 MG | 1件: Elafibranor Elafibranor | 1件: Elafibranor
Elafibranor
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 2件: 93 93, 94 💬
|
41 | Endoluminal bile duct brachytherapy | - | - | - | - | 1件: 94 94 💬
|
42 | Engineered recombinant human FGF19 | - | - | - | - | 1件: 94 94 💬
|
43 | Entyvio | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 💬
|
44 | EP547 | - | - | - | - | 2件: 93 93, 94 💬
|
45 | EP547 tablet 25MG | - | - | - | - | 2件: 93 93, 94 💬
|
46 | EP547 tablet 75MG | - | - | - | - | 2件: 93 93, 94 💬
|
47 | Erlotinib | 1件: Erlotinib Erlotinib | 2件: Erlotinib hydrochloride
Erlotinib hydrochloride
,
Erlotinib
💬
| 1件: EGFR EGFR 💬
| 47件: Adherens junction Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬 | 2件: 94 94, 160 💬
|
48 | Faecal microbiota transplant | - | - | - | - | 2件: 94 94, 97 💬
|
49 | Fecal microbiota transplantation | 1件: Fecal microbiota Fecal microbiota | - | - | - | 10件: 2 2, 6, 13, 63, 66, 94, 96, 97, 99, 271 💬
|
50 | Fenofibrate | 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate
Fenofibrate
💬
| 1件: NR1C1 NR1C1 💬
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 6件: 8 8, 79, 93, 94, 97, 265 💬
|
51 | Fluimucil*20CPR EFF 600MG | - | - | - | - | 2件: 94 94, 298 💬
|
52 | Genetic analysis | - | - | - | - | 7件: 34 34, 85, 90, 93, 94, 96, 234 💬
|
53 | GFT505 | - | - | - | - | 2件: 93 93, 94 💬
|
54 | Gluten-free diet | - | - | - | - | 2件: 94 94, 97 💬
|
55 | GS-6624 | 1件: Simtuzumab Simtuzumab | - | - | - | 2件: 85 85, 94 💬
|
56 | GS-9674 | - | - | - | - | 2件: 93 93, 94 💬
|
57 | HK-660S | - | - | - | - | 1件: 94 94 💬
|
58 | HK-660S 100MG | - | - | - | - | 1件: 94 94 💬
|
59 | HK-660S 200MG | - | - | - | - | 1件: 94 94 💬
|
60 | HTD1801 | - | - | - | - | 1件: 94 94 💬
|
61 | Humanised IGG1 monoclonal antibody against human eotaxin-2 | - | - | - | - | 1件: 94 94 💬
|
62 | Hymecromone | 1件: Hymecromone Hymecromone | 1件: Hymecromone
Hymecromone
💬
| - | - | 2件: 85 85, 94 💬
|
63 | ICG | - | - | - | - | 3件: 93 93, 94, 235 💬
|
64 | INT-747, OCA | - | - | - | - | 2件: 93 93, 94 💬
|
65 | IPN60190 | - | - | - | - | 2件: 93 93, 94 💬
|
66 | LB-P8 HIGH-dose | 1件: LB-P8 LB-P8 | - | - | - | 1件: 94 94 💬
|
67 | LB-P8 LOW-dose | 1件: LB-P8 LB-P8 | - | - | - | 1件: 94 94 💬
|
68 | Levovanox | - | - | - | - | 2件: 94 94, 97 💬
|
69 | Liver transplantation | - | - | - | - | 1件: 94 94 💬
|
70 | LUM001 | - | - | - | - | 5件: 93 93, 94, 296, 297, 338 💬
|
71 | MBX-8025 | - | - | - | - | 3件: 79 79, 93, 94 💬
|
72 | Methionine | 1件: Methionine Methionine | 1件: Methionine
Methionine
💬
| - | - | 6件: 34 34, 75, 84, 94, 298, 300 💬
|
73 | Metronidazole | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 💬
|
74 | Minocycline | 1件: Minocycline Minocycline | 2件: Minocycline hydrochloride
Minocycline hydrochloride
,
Minocycline
💬
| - | - | 14件: 2 2, 6, 8, 13, 46, 85, 90, 94, 97, 162, 201, 206, 280, 299 💬
|
75 | Mitomycin C | 1件: Mitomycin Mitomycin | 1件: Mitomycin
Mitomycin
💬
| - | - | 1件: 94 94 💬
|
76 | Mizoribine | 1件: Mizoribine Mizoribine | 1件: Mizoribine
Mizoribine
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 8件: 46 46, 49, 51, 53, 66, 94, 222, 224 💬
|
77 | MLN0002 | - | - | - | - | 3件: 94 94, 96, 97 💬
|
78 | NGM282 | - | - | - | - | 2件: 93 93, 94 💬
|
79 | Normal saline | - | - | - | - | 20件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
|
80 | Norucholic acid | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | 1件: 94 94 💬
|
81 | Norudca | - | - | - | - | 1件: 94 94 💬
|
82 | Norursodeoxycholic acid | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | 1件: 94 94 💬
|
83 | Norursodeoxycholic acid, NCA | 1件: norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | 1件: 94 94 💬
|
84 | OCA | - | - | - | - | 3件: 93 93, 94, 296 💬
|
85 | OCA 1,5 MG | - | - | - | - | 1件: 94 94 💬
|
86 | OCA 5 MG | - | - | - | - | 1件: 94 94 💬
|
87 | Oral vancomycin | - | - | - | - | 3件: 94 94, 97, 296 💬
|
88 | Oral vancomycin and oral amoxicillin | - | - | - | - | 1件: 94 94 💬
|
89 | Orbcel-C | 1件: Allogenic Donor CD362-enriched Human Umbilical Cord-derived Mesenchymal Stem Cells Allogenic Donor CD362-enriched Human Umbilical Cord-derived Mesenchymal Stem Cells | - | - | - | 2件: 94 94, 95 💬
|
90 | Phenylbutyrate | 1件: Phenylbutyric acid Phenylbutyric acid | 1件: Sodium phenylbutyrate
Sodium phenylbutyrate
💬
| - | - | 7件: 2 2, 93, 94, 244, 251, 297, 338 💬
|
91 | PLN-74809 | 1件: PLN-74809 PLN-74809 | - | - | - | 2件: 85 85, 94 💬
|
92 | PRE liver transplantation laparoscopic hand assisted staging | - | - | - | - | 1件: 94 94 💬
|
93 | Probiotics | - | - | - | - | 6件: 6 6, 94, 96, 97, 206, 291 💬
|
94 | Radiotracer injection | - | - | - | - | 2件: 94 94, 96 💬
|
95 | REC-H-FGF19 | - | - | - | - | 1件: 94 94 💬
|
96 | Ritivixibat | 1件: Ritivixibat Ritivixibat | - | - | - | 1件: 94 94 💬
|
97 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
98 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 9件: 6 6, 18, 46, 49, 51, 79, 94, 96, 271 💬
|
99 | Same | 1件: Ademetionine Ademetionine | 1件: Ademetionine
Ademetionine
💬
| - | - | 1件: 94 94 💬
|
100 | Seladelpar | 1件: Seladelpar Seladelpar | 2件: Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 2件: 93 93, 94 💬
|
101 | Simtuzimab | - | - | - | - | 1件: 94 94 💬
|
102 | Simtuzumab | 1件: Simtuzumab Simtuzumab | - | - | - | 2件: 85 85, 94 💬
|
103 | Simvastatin 40MG | 1件: Simvastatin Simvastatin | 1件: Simvastatin
Simvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 94 94 💬
|
104 | Siplizumab | 1件: Siplizumab Siplizumab | 1件: Siplizumab
Siplizumab
💬
| 1件: CD2 CD2 💬
| 2件: Cell adhesion molecules Cell adhesion molecules, Hematopoietic cell lineage 💬 | 2件: 94 94, 95 💬
|
105 | Sulfasalazine | 1件: Sulfasalazine Sulfasalazine | 1件: Sulfasalazine
Sulfasalazine
💬
| - | - | 6件: 46 46, 86, 94, 107, 270, 271 💬
|
106 | TBC | - | - | - | - | 4件: 85 85, 94, 96, 127 💬
|
107 | Thalidomide | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300 💬
|
108 | Ucmsc | - | - | - | - | 2件: 51 51, 94 💬
|
109 | Udca | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 5件: 67 67, 93, 94, 97, 296 💬
|
110 | Ursodeoxycholic acid | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 8件: 6 6, 67, 84, 93, 94, 95, 96, 97 💬
|
111 | Ursofalk | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 4件: 93 93, 94, 96, 97 💬
|
112 | Ursolic acid | 1件: Ursolic acid Ursolic acid | - | - | - | 1件: 94 94 💬
|
113 | Vancomicina cloridrato | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 2件: 94 94, 97 💬
|
114 | Vancomycin | 1件: Vancomycin Vancomycin | 2件: Vancomycin
Vancomycin
,
Vancomycin hydrochloride
💬
| - | - | 8件: 13 13, 46, 70, 94, 96, 97, 296, 299 💬
|
115 | Vedolizumab | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 💬
|
116 | Vedolizumab IV | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 💬
|
117 | Vidofludimus calcium | 1件: Vidofludimus Vidofludimus | 2件: Vidofludimus
Vidofludimus
,
Vidofludimus calcium
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 4件: 13 13, 94, 96, 97 💬
|
118 | Volixibat | 1件: Volixibat Volixibat | 2件: Volixibat potassium
Volixibat potassium
,
Volixibat
💬
| - | - | 2件: 93 93, 94 💬
|
119 | Volixibat potassium | 1件: Volixibat Volixibat | 2件: Volixibat potassium
Volixibat potassium
,
Volixibat
💬
| - | - | 2件: 93 93, 94 💬
|
120 | Xifaxan | - | - | - | - | 2件: 65 65, 94 💬
|